BSE Live
Dec 03, 11:17Prev. Close
6416.70
Open Price
6425.05
Bid Price (Qty.)
6386.45 (8)
Offer Price (Qty.)
6392.15 (13)
NSE Live
Dec 03, 11:17Prev. Close
6417.50
Open Price
6419.50
Bid Price (Qty.)
6388.00 (3)
Offer Price (Qty.)
6389.00 (8)
| Key Financial Ratios of Divis Laboratories (in Rs. Cr.) | Mar 20 | Mar 19 | Mar 18 | Mar 17 | Mar 16 | |
| Per Share Ratios | ||||||
| Basic EPS (Rs.) | 51.71 | 50.20 | 32.76 | 39.68 | 41.73 | |
| Diluted EPS (Rs.) | 51.71 | 50.20 | 32.76 | 39.68 | 41.73 | |
| Cash EPS (Rs.) | 58.72 | 56.56 | 38.12 | 44.32 | 46.17 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 275.63 | 262.70 | 224.51 | 203.76 | 163.87 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 275.63 | 262.70 | 224.51 | 203.76 | 163.87 | |
| Dividend / Share(Rs.) | 16.00 | 16.00 | 10.00 | 10.00 | 10.00 | |
| Revenue from Operations/Share (Rs.) | 200.06 | 183.83 | 143.75 | 151.59 | 140.18 | |
| PBDIT/Share (Rs.) | 75.54 | 75.55 | 51.35 | 57.03 | 56.21 | |
| PBIT/Share (Rs.) | 68.54 | 69.19 | 45.99 | 52.38 | 51.76 | |
| PBT/Share (Rs.) | 68.31 | 69.06 | 45.94 | 52.30 | 51.68 | |
| Net Profit/Share (Rs.) | 51.71 | 50.20 | 32.76 | 39.68 | 41.73 | |
| Profitability Ratios | ||||||
| PBDIT Margin (%) | 37.76 | 41.09 | 35.72 | 37.61 | 40.10 | |
| PBIT Margin (%) | 34.25 | 37.64 | 31.98 | 34.55 | 36.92 | |
| PBT Margin (%) | 34.14 | 37.56 | 31.95 | 34.50 | 36.86 | |
| Net Profit Margin (%) | 25.84 | 27.31 | 22.78 | 26.17 | 29.76 | |
| Return on Networth / Equity (%) | 18.76 | 19.11 | 14.59 | 19.47 | 25.46 | |
| Return on Capital Employed (%) | 23.90 | 25.48 | 19.79 | 25.03 | 24.55 | |
| Return on Assets (%) | 16.12 | 16.57 | 12.77 | 16.96 | 22.03 | |
| Total Debt/Equity (X) | 0.00 | 0.02 | 0.01 | 0.01 | 0.01 | |
| Asset Turnover Ratio (%) | 62.37 | 60.69 | 56.05 | 64.79 | 74.01 | |
| Liquidity Ratios | ||||||
| Current Ratio (X) | 5.16 | 5.58 | 7.11 | 6.16 | 6.04 | |
| Quick Ratio (X) | 3.23 | 3.58 | 5.11 | 4.24 | 3.79 | |
| Inventory Turnover Ratio (X) | 3.04 | 2.93 | 2.98 | 3.20 | 3.20 | |
| Dividend Payout Ratio (NP) (%) | 61.88 | 19.92 | 30.52 | 0.00 | 23.96 | |
| Dividend Payout Ratio (CP) (%) | 54.50 | 17.68 | 26.23 | 0.00 | 21.65 | |
| Earnings Retention Ratio (%) | 38.12 | 80.08 | 69.48 | 0.00 | 76.04 | |
| Cash Earnings Retention Ratio (%) | 45.50 | 82.32 | 73.77 | 0.00 | 78.35 | |
| Valuation Ratios | ||||||
| Enterprise Value (Cr.) | 52,685.78 | 45,211.84 | 28,892.41 | 16,537.33 | 26,134.20 | |
| EV/Net Operating Revenue (X) | 9.92 | 9.27 | 7.57 | 4.11 | 7.02 | |
| EV/EBITDA (X) | 26.27 | 22.54 | 21.20 | 10.92 | 17.51 | |
| MarketCap/Net Operating Revenue (X) | 9.93 | 9.27 | 7.58 | 4.12 | 7.03 | |
| Retention Ratios (%) | 38.11 | 80.07 | 69.47 | 0.00 | 76.03 | |
| Price/BV (X) | 7.21 | 6.48 | 4.85 | 3.06 | 6.01 | |
| Price/Net Operating Revenue | 9.93 | 9.27 | 7.58 | 4.12 | 7.03 | |
| Earnings Yield | 0.03 | 0.03 | 0.03 | 0.06 | 0.04 |
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
12.11.2025
Divis Labs Standalone September 2025 Net Sales at Rs 2,660.00 crore, up 15.55% Y-o-Y
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill